PDCD1 and non-small cell lung carcinoma: Although the development of irAEs correlates with improved efficacy of PD-1/PD-L1 inhibitors [82], ICI-related pneumonitis and myocarditis of any grade have been associated with decreased survival in NSCLC patients [83, 84].